FAKTOR-OPTIONSSCHEIN - INMODE Stock

Certificat

DE000MG31LB7

Market Closed - Börse Stuttgart 12:03:51 2024-05-31 EDT
7.23 EUR +4.18% Intraday chart for FAKTOR-OPTIONSSCHEIN - INMODE
Current month-29.74%
1 month-29.74%
Date Price Change
24-05-31 7.23 +4.18%
24-05-30 6.94 -0.14%
24-05-29 6.95 -6.08%
24-05-28 7.4 -2.50%
24-05-27 7.59 -3.31%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 12:03 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying INMODE LTD.
Issuer Morgan Stanley
WKN MG31LB
ISINDE000MG31LB7
Date issued 2024-04-25
Strike 25.16 $
Maturity Unlimited
Parity 0.82 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.81
Lowest since issue 6.41
Spread 0.04
Spread %0.58%

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
19.13 USD
Average target price
25.6 USD
Spread / Average Target
+33.82%
Consensus